NCT05934513
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Sun Yat-sen University Cancer Center Guanzhou, Guangdong, China
Clinical trial condition
Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Explore clinical trials studying Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL). Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) trial results
Active, Not Recruiting
A Phase IIa Clinical Study of Purinostat Mesylate for Injection in Patients With Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma
NCT06485219
- Conditions
- Cutaneous T-cell Lymphoma (CTCL), Disease Attributes, Hemic and Lymphatic Diseases, +15 more
- Locations
-
- Ruijin Hospital, Shanghai Jiaotong University School Of Medicine Shanghai, Shanghai Municipality, China
- West China Hospital Sichuan University Chengdu, Sichuan, China